Tissue/Organ
Biocybernetics
Organ Growth
Xenotransplantation
3D Bio-printing
Nano
Diagnostic Tools
Micro-surgery
Targeted Delivery
Senescence
Senolytic drugs
Telomeres
Cellular
Mitochondria
Gene editing
Stem Cells
Drugs
Development
Clinical trials
Indication expansion
AI
Diagnosis
Intervention
Digital health
Neural
Neural integration
Singularity
Agetech
Independent living
Diet
Wellness
Longevity finance
Investment
Events
TV
Longevity 2020
Defining biological aging
Rejuvenation therapies
AI & Longevity
Longevity investing
Longevity start now
Free to view
Store
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Newsletter Signup
Basket
Checkout
My account
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Longevity.Technology
Tissue/Organ
All
Biocybernetics
Organ Growth
Xenotransplantation
3D Bio-printing
Wellness
Longevity Escape Velocity within 10 years?
Tissue/Organ
New Buck Institute research is big news for Longevity
Mitochondria
Gut health shines a light on Longevity
Tissue/Organ
Study linking heart health to brain health could delay dementia
Nano
All
Diagnostic Tools
Micro-surgery
Targeted Delivery
Wellness
Longevity Escape Velocity within 10 years?
Nanotech
Nanoparticles to strip away senescent cell defences
Targeted Delivery
Nano drug-delivery system developed for neurological disorders
Investment
Clene goes for gold, and goes public
Senescence
All
Senolytic drugs
Telomeres
Senescence
Clearance of senescent cells for improved cognition
Wellness
Longevity Escape Velocity within 10 years?
Development
AI to quantify senescent cell counts
Senolytic drugs
Senolytic start-up gears up for clinical trials
Cellular
All
Mitochondria
Gene editing
Stem Cells
Mitochondria
Harvard spin-off Cellvie Inc closes $5M seed round
Senescence
Clearance of senescent cells for improved cognition
Cellular
Promising restorative therapy potentially 5 years away
Wellness
Longevity Escape Velocity within 10 years?
Drugs
All
Development
Clinical trials
Indication expansion
Wellness
Proving the Longevity potential of spermidine
Wellness
Longevity Escape Velocity within 10 years?
Cellular
“Adjust the immune system… de-age the brain”
Development
AI to quantify senescent cell counts
AI
All
Diagnosis
Intervention
Digital health
Wellness
Longevity Escape Velocity within 10 years?
Development
AI to quantify senescent cell counts
Investment
Longevity companies to watch in 2021
Development
A year in Longevity: progress perspectives
Neural
All
Neural integration
Singularity
Wellness
Longevity Escape Velocity within 10 years?
Tissue/Organ
Study linking heart health to brain health could delay dementia
Targeted Delivery
Nano drug-delivery system developed for neurological disorders
Wellness
Rise of the superagers – sharp minds and youthful cognition
Agetech
All
Independent living
Diet
Wellness
Longevity finance
Wellness
Going deeper on ketone analysis for longevity
Wellness
Proving the Longevity potential of spermidine
Senescence
Clearance of senescent cells for improved cognition
Wellness
Longevity Escape Velocity within 10 years?
Investment
Events
TV
All
Longevity 2020
Defining biological aging
Rejuvenation therapies
AI & Longevity
Longevity investing
Longevity start now
Free to view
Longevity TV
Investing in the age of Longevity: Investment panel
Longevity TV
Investing in the age of Longevity: Science panel
Investment
Startup Showcase: Rejuvenate Biomed: What do you think?
Longevity TV
Exclusive video interview with Dave Asprey
Store
Longevity 2020
Defining biological aging
Longevity TV
Towards a consensus definition of biological aging
Phil Newman
-
April 27, 2020
0
Attila Csordas, Founder & Director, AgeCurve Ltd.
Read more
Longevity TV
Reversal of several aging pathways & diseases
Phil Newman
-
April 27, 2020
0
George Church, Founding Core Faculty & Lead, Synthetic Biology, Wyss Institute at Harvard University.
Read more
Longevity TV
Leveraging aging science (geroscience) to improve older adults’ immune health
Phil Newman
-
April 27, 2020
0
Nir Barzilai, Director, Institute for Aging Research.
Read more
Longevity TV
Connections & differences between different hallmark processes
Phil Newman
-
April 27, 2020
0
Lynne Cox, Associate Professor in Biochemistry, University of Oxford.
Read more
More from 'Defining biological aging'
Rejuvenation therapies
Longevity TV
The divide-and-conquer nature of rejuvenation can be an asset, not a challenge
Phil Newman
-
April 28, 2020
0
Aubrey de Grey, Founder and CEO, SENS Foundation.
Read more
Longevity 2020
The use of TORC1 inhibitors to improve immune function in the elderly
Phil Newman
-
April 28, 2020
0
Joan Mannick, Chief Medical Officer, resTORbio
Read more
Longevity TV
How do we show in humans that a drug targets aging?
Phil Newman
-
April 28, 2020
0
Nir Barzilai, Director, Institute for Aging Research
Read more
Longevity TV
Geroprotectors: time to change the way we treat older people?
Phil Newman
-
April 28, 2020
0
Ilaria Bellantuono, Professor in Musculoskeletal Ageing, Co-Director, The Healthy Lifespan Institute, Department of Oncology and Metabolism
Read more
More from 'Rejuvenation therapies'
AI & Longevity
Longevity TV
Extending healthspan with NaNot nano-extractors
Phil Newman
-
April 29, 2020
0
Lou Hawthorne, CEO, NaNotics
Read more
Longevity TV
Interview with Margaretta Colangelo
Phil Newman
-
April 29, 2020
0
Margaretta Colangelo, Co-founder / Managing Partner, Deep Knowledge Ventures / Longevity.Capital / Deep Knowledge Analytics
Read more
Longevity TV
Applying AI approaches to diverse aging-related problems
Phil Newman
-
April 29, 2020
0
Alexander Zhavoronkov, Chief Executive Officer, Insilico Medicine, Inc
Read more
Longevity TV
Margaretta Colangelo in conversation with Richard Siow, John Shepherd, and Alexander Zhavoronkov
Phil Newman
-
April 29, 2020
0
Margaretta Colangelo, Co-founder / Managing Partner, Deep Knowledge Ventures / Longevity.Capital / Deep Knowledge Analytics
Read more
More from 'AI & Longevity'
Longevity investing
Longevity TV
The Big Picture: Covid-19 and Longevity investing
Phil Newman
-
April 30, 2020
0
Jim Mellon, Chairman and Founder, Burnbrae Group
Read more
Longevity TV
The view from the valley
Phil Newman
-
April 30, 2020
0
Kate Batz, Managing Partner, Longevity Capital and Director of Strategy at Deep Knowledge Ventures and Aging Analytics Agency.
Read more
Longevity TV
Accelerating agetech
Phil Newman
-
April 30, 2020
0
Lorraine Morley, UK Lead / Advisor, AgeTech Accelerator
Read more
Longevity TV
The Juvenescence business model and future of anti-aging
Phil Newman
-
April 30, 2020
0
Greg Bailey, CEO, Juvenescence
Read more
More from 'Longevity investing'
Longevity start now
Longevity TV
Longevity: Start now … Introduction
Phil Newman
-
May 1, 2020
0
Johnny Adams, CEO / Executive Director, Aging Intervention Foundation; Executive Director, Gerontology Research Group
Read more
Longevity TV
Early access to the treatment of aging: distinguishing rational self-experimentation from arrant foolishness
Phil Newman
-
May 1, 2020
0
Reason, Co-founder and CEO, Repair Biotechnologies & Fight Aging!
Read more
Longevity TV
Rejuvant – starting Longevity now
Phil Newman
-
May 1, 2020
0
Tom Weldon, Founder, Executive Chairman, Acting CEO, Ponce De Leon Health
Read more
Longevity TV
How can BioViva address the here and now?
Phil Newman
-
May 1, 2020
0
Liz Parrish, CEO, BioViva Sciences
Read more
More from 'Longevity start now'
Latest articles
Going deeper on ketone analysis for longevity
Wellness
Harvard spin-off Cellvie Inc closes $5M seed round
Mitochondria
Proving the Longevity potential of spermidine
Wellness
Clearance of senescent cells for improved cognition
Senescence
Home
Tissue/Organ
Nano
Senescence
Cellular
Drugs
AI
Neural
Agetech
Investment
Newsletter Signup
Events
Longevity TV
Store
Basket
Checkout
My account